UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Nature reviews cardiology, 2022-07, Vol.19 (7), p.475-495

2022

Volltextzugriff (PDF)

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Thrombosis and haemostasis, 2020-11, Vol.120 (11), p.1594-1596

2020

Volltextzugriff (PDF)

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

European heart journal, 2015-07, Vol.36 (27), p.1762-1771

2015

Volltextzugriff (PDF)

G-protein-coupled receptors signaling pathways in new antiplatelet drug development

Arteriosclerosis, thrombosis, and vascular biology, 2015-03, Vol.35 (3), p.500-512

2015

Volltextzugriff (PDF)

GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes

The Lancet (British edition), 2017-05, Vol.389 (10081), p.1773-1775

2017

Volltextzugriff (PDF)

First report of the point-of-care TEG: A technical validation study of the TEG-6S system

Platelets (Edinburgh), 2016-10, Vol.27 (7), p.642-649

2016

Volltextzugriff (PDF)

Meta-Analysis of the Usefulness of Therapeutic Hypothermia After Cardiac Arrest

The American journal of cardiology, 2020-10, Vol.133, p.48-53

2020

Volltextzugriff (PDF)

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry

Platelets (Edinburgh), 2024-12, Vol.35 (1), p.2298352-2298352

2024

Volltextzugriff (PDF)

Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis

The American heart journal, 2014-10, Vol.168 (4), p.530-536

2014

Volltextzugriff (PDF)

The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation

Platelets (Edinburgh), 2022-05, Vol.33 (4), p.520-530

2022

Volltextzugriff (PDF)

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences

Korean Circulation Journal, 2021, 51(3), , pp.202-221

2021

Volltextzugriff (PDF)

Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?

The Annals of thoracic surgery, 2016-12, Vol.102 (6), p.2010-2017

2016

Volltextzugriff (PDF)

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

The American journal of cardiology, 2016-12, Vol.118 (12), p.1941-1947

2016

Volltextzugriff (PDF)

Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?

Current vascular pharmacology, 2018-01, Vol.16 (5), p.459-476

2018

Volltextzugriff (PDF)

Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring

Current pharmaceutical design, 2013, Vol.19 (21), p.3795-3815

2013

Volltextzugriff (PDF)

Antiplatelet and Anticoagulant Agents in Heart Failure

JACC. Heart failure, 2014-02, Vol.2 (1), p.1-14

2014

Volltextzugriff (PDF)

Antithrombotic Strategies and Device Thrombosis

Cardiology clinics, 2018-11, Vol.36 (4), p.541-550

2018

Volltextzugriff (PDF)

Drug Insight: clopidogrel nonresponsiveness

Nature clinical practice cardiovascular medicine, 2006-07, Vol.3 (7), p.387-395

2006

Volltextzugriff (PDF)

Thromboembolism after WATCHMANTM in a clopidogrel non‐responder: A case for concern?

Catheterization and cardiovascular interventions, 2018-07, Vol.92 (1), p.200-202

2018

Volltextzugriff (PDF)

Resistance to antiplatelet drugs: what progress has been made?

Expert opinion on pharmacotherapy, 2014-12, Vol.15 (17), p.2553-2564

2014

Volltextzugriff (PDF)

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations

EClinicalMedicine, 2020-12, Vol.29-30, p.100647-100647, Article 100647

2020

Volltextzugriff (PDF)

The Effect of St Johnʼs Wort on the Pharmacodynamic Response of Clopidogrel in Hyporesponsive Volunteers and Patients: Increased Platelet Inhibition by Enhancement of CYP3A4 Metabolic Activity

Journal of cardiovascular pharmacology, 2011-01, Vol.57 (1), p.86-93

2011

Volltextzugriff (PDF)

Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications

Current heart failure reports, 2016-12, Vol.13 (6), p.319-328

2016

Volltextzugriff (PDF)

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for Therapy?

Korean Circulation Journal, 2020, 50(9), , pp.817-821

2020

Volltextzugriff (PDF)

Temporal Variability of Platelet Reactivity Phenotype: Another Barrier to Personalized Antiplatelet Strategy Guided by Platelet Function Testing

Korean Circulation Journal, 2019, 49(11), , pp.1062-1065

2019

Volltextzugriff (PDF)

1 – 25 von 493

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(451)
Mit Volltextzugriff
(382)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(261)
Life Sciences & Biomedicine
(259)
Humans
(192)
Cardiovascular System & Cardiology
(181)
Cardiac & Cardiovascular Systems
(162)
Cardiology
(75)
Male
(69)
Platelet Aggregation Inhibitors - Therapeutic Use
(69)
Cardiovascular
(67)
Female
(63)
Ticlopidine - Analogs & Derivatives
(62)
Clopidogrel
(61)
Aspirin
(55)
Hematology
(54)
Peripheral Vascular Disease
(53)
Internal Medicine
(44)
Middle Aged
(43)
Thrombosis
(42)
Cardiovascular Disease
(41)
Treatment Outcome
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

G-protein-coupled receptors signaling pathways in new antiplatelet drug development

GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes

First report of the point-of-care TEG: A technical validation study of the TEG-6S system

Meta-Analysis of the Usefulness of Therapeutic Hypothermia After Cardiac Arrest

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry

Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis

The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences

Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?

Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring

Antiplatelet and Anticoagulant Agents in Heart Failure

Antithrombotic Strategies and Device Thrombosis

Drug Insight: clopidogrel nonresponsiveness

Thromboembolism after WATCHMANTM in a clopidogrel non‐responder: A case for concern?

Resistance to antiplatelet drugs: what progress has been made?

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations

The Effect of St Johnʼs Wort on the Pharmacodynamic Response of Clopidogrel in Hyporesponsive Volunteers and Patients: Increased Platelet Inhibition by Enhancement of CYP3A4 Metabolic Activity

Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for Therapy?

Temporal Variability of Platelet Reactivity Phenotype: Another Barrier to Personalized Antiplatelet Strategy Guided by Platelet Function Testing

Aktive Filter

Suchergebnisse filtern